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Background: Spinocerebellar ataxia type 1 (SCA1) is a late onset autosomal dominant cerebellar ataxia, caused by
CAG triplet repeat expansion in the ATXN1 gene. The frequency of SCA1 occurrence is more in Southern India than
in other regions as observed from hospital-based studies. However there are no reports on variability of CAG repeat
expansion, phenotype-genotype association and founder mutations in a homogenous population from India.
Methods: Genomic DNA isolated from buccal mouthwash of the individuals in the cohort was used for PCR-based
diagnosis of SCA1. Subsequently SNP’s found within the ATXN1 loci were identified by Taqman allelic discrimination
assays. Significance testing of the genotype-phenotype associations was calculated by Kruskal-Wallis ANOVA test
with post-hoc Dunnett’s test and Pearson’s correlation coefficient.
Results: By genetic analysis of an affected population in Southern India we identified 21 pre-symptomatic individuals
including four that were well past the average age of disease onset of 44 years, 16 symptomatic and 63 normal individuals.
All pre-symptomatic cases harbor “pure” expansions of greater than 40 CAGs. Genotyping to test for the presence of two
previously identified SNPs showed a founder effect of the same repeat carrying allele as in the general Indian population.
We show that SCA1 disease onset is significantly delayed when transmission of the disease is maternal.
Conclusions: Our finding of early disease onset in individuals with a paternally inherited allele could serve as valuable
information for clinicians towards early detection of SCA1 in patients with affected fathers. Identification of older
pre-symptomatic individuals (n = 4) in our cohort among individuals with a shared genetic and environmental
background, suggests that second site genetic or epigenetic modifiers might significantly affect SCA1 disease progression.
Moreover, such undetected SCA1 cases could underscore the true prevalence of SCA1 in India.
Keywords: Spinocerebellar ataxia 1, Cohort, Pre-symptomatic, Founder mutationBackground
Spinocerebellar ataxias (SCAs) are late onset, clinically
and genetically heterogeneous neurodegenerative disorders
broadly comprising of progressive cerebellar ataxia with
variable involvement of the brain stem and spinal cord [1].
Amongst the SCAs, SCA1 was the first to be genetically
characterized with an expansion of translated CAG
trinucleotide repeats located within exon 8 of the ATXN1
gene [2]. The repeat number is polymorphic and varies
between 4 and 36 repeats. While in normal individuals,
this repeat sequence may be occasionally interrupted by* Correspondence: gaiti@ncbs.res.in
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unless otherwise stated.1–3 CAT triplets, in SCA1 patients the repeats are
expanded beyond 39 and are uninterrupted [3]. CAT in-
terruptions among CAG repeats are postulated to prevent
repeat expansion and contraction during DNA replication
and repair. They are also known to enhance the stability
of the repeat tract and thus render them non-pathogenic
[4,5]. Therefore, molecular characterization of expanded
repeats at the SCA1 locus is essential to allow both genetic
counseling and to understand disease pathogenesis.
SCA1 occurs in diverse ethnic groups worldwide with
varying prevalence [6-12]. In India, SCA1 accounts for
22% of ADCA (Autosomal Dominant Cerebellar Ataxia)
[13]. Previous studies in the Indian population have
studied the prevalence of SCA1 in hospital cases [13-17]
where a higher frequency of SCA1 has been seen inal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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etic basis, such as founder mutations, frequency of large
normal alleles (>30 repeats) and presence of CAT inter-
ruptions [13]. Small pockets of villages have been
reported in Tamil Nadu in South India with a high
prevalence of SCA1 [18]. But, genotypic studies, such as
those done in the hospital cases, have not been
conducted in these isolated communities of South India.
Additionally, studies investigating disease onset in indi-
viduals living in homogenous conditions in order to
understand phenotypic variability in individuals with
shared genetic background and environment influences
have not been conducted in India. We chose patients
and their families from Adukkamparai, a village located
in an area of South India, where a high prevalence of
hereditary ataxia was recorded previously [18]. The
study aimed to understand the genetic basis of ataxia in
these patients and compare the manifestation of disease




All adults (48 males and 52 females) residing at
Adukkamparai village in Vellore India, who agreed to
participate (henceforth referred to as the cohort) were
recruited in this study. The entire cohort, consisting of
unaffected family members, members with progressive
and non-progressive ataxia and first-degree relatives of the
affected patients was evaluated. The clinical team com-
prised of investigators from departments of Community
health, Neurology, Clinical genetics and Neurobiology
from the two institutions. The Institutional review board
of Christian Medical College and Hospital Vellore (Blue,
Research and Ethics committee) approved the study (IRB
Min no: 7692 dated 12.12.2011).
A detailed pedigree chart was constructed with em-
phasis on age of onset, severity, anticipation and pater-
nal/maternal inheritance patterns using Haplopainter
V1.043 software [19]. Other details such as ethnicity,
geographic location of ancestors and occupation were
also collected.
DNA extraction
Buccal cells were collected from 100 individuals (48
males and 52 females) of the 15 families after in-
formed consent. The cells were obtained from mouth-
washes performed with 10 ml autoclaved double
distilled water. They were stored at 4°C before pro-
cessing for DNA extraction. DNA samples were ob-
tained from cells that had been stored up to 20 days.
Samples were centrifuged at 6000 rpm for 5 minutes
so as to pellet the cells. DNA was isolated from the
buccal epithelial cell pellet using the HiPurA BuccalDNA Miniprep Purification Spin columns (Hi-Media
Pvt. Ltd, Mumbai, India) according to the manufac-
turer’s protocol.
Analysis of CAG repeats and CAT interruptions
The isolated DNA was used to carry out PCR based assays
for diagnosis of SCA1 with the rep1 and rep2 primers [20]
and SCA2 specific primers (SCA2 A-B) [21] according to
published protocols. Fragment analysis was performed with
PCR products obtained by FAM-labeled rep2 primers and
regular rep1 primers. The PCR products (1 μl) were mixed
with 12 μl of formamide, and 0.7 μl LIZ-500 (Applied
Biosystems, Life Technologies, Foster City, CA, USA)
containing the molecular size standards for reference. Sam-
ples were denatured at 95°C for 10 min, placed on ice and
subjected to capillary electrophoresis on an ABI genetic
analyzer 3130xl. Data was analyzed using PeakScanner V2
software (Applied Biosystems, Life Technologies, Foster
City, CA). The number of base pairs (bp) of CAG repeats
was calculated by taking the size of the PCR product and
subtracting 123 from it followed by dividing by 3; 123 bp is
the size of the non-repeat region in the amplified product.
CAT interruption of the CAG repeats was assessed on
the basis of restriction digestion of the PCR product with
SfaNI, which cleaves the PCR product in the presence of
CAT trinucleotides [22].
SNP analysis
Analysis of two SNPs, rs2075974 and rs1476464 in the
ATXN1 gene was performed by the Taqman allelic dis-
crimination assay obtained from Applied Biosystems,
Life technologies. Approximately 20–50 ng of genomic
DNA was mixed with 12.5 μL of SNP genotyping mas-
ter mix and 1.25 μl of 20X primer probe mix (Life tech-
nologies pre-designed SNP genotyping assay, part
number C__16167072_10 for rs2075974 and part number
C__7615001_10 for rs1476464) and run on the Applied
Biosystems 7500 fast real time PCR system. The cycling
temperatures were as follows: denaturation at 95°C for
10 minutes followed by 40 cycles of 95°C for 15 sec and
60°C for 1 minute. A particular SNP is identified by the
corresponding amplification peak and is confirmed by the
allelic calls generated by the 7500-software v2.0.5.
Statistical analysis
The relationship between age of onset and inheritance with
CAG repeats was calculated by Kruskal-Wallis ANOVA
test with post-hoc Dunnett’s test. Pearson’s correlation coef-
ficient was used to test linear association between repeat
length and age of onset. Chi-square test and one-way
ANOVA was used to test significance of qualitative data.
Significance was calculated using the GraphPad Prism 6.0
software and results were considered significant at P = 0.05
level.
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Clinical and pedigree analysis of the cohort
All 100 individuals studied were residents of Addukkamparai
for 20 years or more. These individuals belong to a group
that have been practising consanguineous marriage for
generations. Amongst this group we identified 16 individuals
from 6 families with clinical symptoms of ataxia (Figure 1)
after a comprehensive examination of cranial nerves,
motor-sensory systems, extrapyramidal systems, periph-
eral nervous system and neurophthalmogic examination.Figure 1 Pedigree of six affected SCA1 families. a) family O, b) family F
as squares and females as circles) are represented as follows; black-filled sym
affected by hearsay; symbols with a line across: expired; open symbols: clini
followed by allele1/allele2 sizes.Family O (Figure 1a) had the maximum number of clinic-
ally affected individuals (n = 7). Two families, F and Q, had
2 and 4 affected individuals respectively (Figure 1b and c)
and 3 families, J, R and G had a single affected individual
(Figure 1d, e and f).
Genetic analysis of the cohort
After PCR based analysis for detection of ATXN1 and
ATXN2 CAG repeats the diagnosis of SCA1 in the families
was confirmed. The number of SCA1 repeats ranged from, c) family Q, d) family J, e) family R and f) family G. Individuals (males
bols: those who were clinically affected; symbols with a vertical line:
cally unaffected. Texts below the symbols indicate the individual code
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(Figure 2a). Repeat sizes of 39 or more, characteristic
of SCA1, were seen in 37 individuals. Among these individ-
uals, 16 (43.24%) had clinical symptoms of ataxia with the
youngest symptomatic individual being 30 years old, but 21
(56.75%) did not show any symptoms. These were classified
as pre-symptomatic. Among the pre-symptomatics, 4 indi-
viduals were older than 45 years at the time of evaluation,
the oldest being 60 years old. The repeat sizes of older pre-
symptomatic individuals were 25/43 (O2, Figure 1a), 28/42
(O27; Figure 1a), 32/43 (J2; Figure 1d) and 24/43 (I5; not
shown). These patients including the oldest among them, a
60 year old female (O2), did not show any clinical features
of the symptomatic individuals such as gait ataxia, tempor-
alis and masseter wasting, bucco-oral and limb dystonia,
night cramps, dysarthria, pale discs, stare and peripheral
neuropathy. To understand the possible contribution of
environmental factors to the absence of SCA1 symptoms in
these individuals (n = 4), we compared their lifestyle with
that of symptomatic individuals in the same age bracket of
greater than 45 years (n = 13). The occupation of such pre-
symptomatic and symptomatic individuals and their use of
tobacco and alcohol were categorized (Table 1). All symp-
tomatic females (n = 5) were housewives (non-smokers and
no alcohol use) with occasional farming activity. Their life-
style and occupation appeared identical to the older pre-
symptomatic females (n = 3). The symptomatic males (n = 8)Figure 2 CAG repeats distribution and analysis of CAT
interruptions in ATXN1 gene. (a) Distribution of CAG repeats in
normal and expanded SCA1 alleles at the ATXN1 locus. (b) PCR
products of ATXN1 gene before (U; undigested) and after (D,
digested) digestion with SfaN1 in the pre-symptomatic individuals I5,
O2, O27 and J2. PC denotes positive control.had a range of occupations such as farming (n = 1), shop-
keeper, small business etc. (n = 7). Regular smoking and
occasional alcohol use was observed in 4 symptomatic
males. The pre-symptomatic older male (O27) had no his-
tory of smoking or alcohol use. Based on these data no
obvious differences in the lifestyle or dietary habits of the
older pre-symptomatic individuals and the symptomatic
individuals could be ascertained.
DNA from all 21 pre-symptomatic patients was tested
for CAT interruptions using SfaNI. Restriction enzyme
SfaNI [recognition sequence: 5’-GCATC(N)53’] cleaves a
CAT interrupted CAG repeat [22]. We found that all
pre-symptomatic individuals, including the four elderly
pre-symptomatics, harbored “pure” CAG expansions
(Figure 2b).
In conclusion, normal range of repeats (24 to 35) was
seen in 63 individuals and expansions ranging from 41–51
were observed in 37 individuals (16 symptomatic and 21
pre-symptomatic). Homozygous states of repeat expansions
were seen in 2 individuals with genotypes of 41/49 (O8)
and 45/46 (O20). O20 (20 years old) is pre-symptomatic
and O8 (43 year old) symptomatic for SCA1 (Figure 1a).
O19 (43 years old) with repeat size 28/47 shows symptoms
as severe as O8, indicating that homozygosity does not
contribute to disease severity. It is previously known that
the disease manifestation in homozygous condition is con-
tributed by the size of the larger allele and the smaller allele
makes no contribution [7,18].
The remaining 35 patients were heterozygous for ex-
panded CAG repeats. Significant changes in repeat num-
bers either expansions or contractions - were not observed
between generations except in family Q (Figure 1c), where
Q6 with the genotype 32/48 has an expansion of 4 CAG’s
from her father Q3 (28/44). Increase in size of CAG repeats
when transmitted from affected fathers is known in SCA1
[22,23].
Correlation of Genotype with the observed Phenotypes
Based on inheritance of the mutant gene we classified
patients into three groups as follows: Group 1 (n = 6), with
a maternally inherited mutated allele; Group 2 (n = 5), with
a paternally inherited mutated allele and Group 3 (n = 5), in
which both the parents were affected. The mean age of on-
set of disease in group 1 was 52.5 ± 4.18 years, whereas in
group 2 it was 40.2 ± 4.81 years and in group 3 it was 38.6 ±
5.17 (Figure 3a). A significant difference was observed in the
ages of onset between the groups 1, 2 and 3 by Kruskal-
Wallis ANOVA test (P = 0.0004). As significant results were
observed we compared group 1 with group 2 and 3 by or-
dinary ANOVA with post hoc Dunnett’s test. Group 1 was
found to be significantly different from group 2 (P = 0.0015)
and group 3 (P = 0.005), whereas no significant difference
was observed between group 2 and 3 (P = 0.8). Thus,
patients with maternally inherited alleles in the cohort show
Table 1 Comparison of occupation and lifestyle habits of older pre-symptomatic individuals with symptomatic SCA1
patients of similar age
Occupation/lifestyle Pre-symptomatic females Symptomatic females Pre-symptomatic males Symptomatic males
House-wife 3 (J2, I5, O2) 5 (O11, O8, O19, Q7, O1) - -
Farming and occasional contract laborers 3 (J2, I5, O2) 4 (O11, O8, O19, O1) 1 (O27) 1 (O18)
Other occupation - - - 7 (O5, F8, Q3, Q1, J5,
G1, Q5)
Tobacco use (smoking) - - - 2 (O18, Q5)
Alcohol consumption (occasional) - - - 2 (O5, F8)
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inherited alleles. When both parents were affected, the age
of onset was determined by the paternal allele. Similar
difference in the age of onset between paternal and mater-
nal inheritance of the CAG expanded chromosome has
been observed in Huntington’s disease [24,25]. To the best
of our knowledge a similar finding has not been described
for SCA1 to date.Figure 3 Genotype-phenotype correlation among the SCA1
affected individuals. (a) Relationship between inheritance pattern
and age of onset of the disease. Data was analyzed using one-way
ANOVA with Dunnett’s multiple comparison test (*P = 0.0015 and
**P = 0.005). (b) Inverse correlation of age of onset with respect to
the CAG expansions in the symptomatic patients (r2 = 0.45 and
P = 0.002), where individuals with maternally inherited alleles are
represented as circles, paternally inherited alleles as squares and
inheritance from both parents as triangles.Correlation of CAG repeats size with age of onset and
inheritance (Figure 3b) showed that both maternal and pa-
ternally transmitted alleles harbored repeat sizes in the range
of 40–45 (shown as circles for maternally transmitted and
squares for paternally transmitted alleles in Figure 3b). Indi-
viduals with both parents affected (triangles in Figure 3b)
had longer repeats. Similar to previous studies [26] the age
of onset of ataxia in the symptomatic individuals (n = 16)
correlated negatively with greater repeat numbers (r =−0.67,
P = 0.002), indicating that 45% (R2 = 0.45) of the variation in
age of onset is accounted by the size of the repeat
(Figure 3b).
Founder mutation
To understand if there was a founder effect of the muta-
tion in this population we looked at the two SNP’s (repre-
sented in Figure 4a) surrounding the CAG expansions.
Allelic discrimination plots for the SNP’s are shown in
Figure 4b, c. SNP1 (rs2075974) and SNP2 (rs1476464) for
35 patients, including the pre-symptomatic elder individ-
uals O2, O27, J2 and I5 mentioned above, showed a clear
association to the G allele. The association of the two
SNPs with normal and SCA1 patients were significantly
different (P = 0.0001; Table 2). The allele G showed associ-
ation with the expanded chromosome at SNP1 and SNP2
(Table 2). Presence of the G allele at both SNP1 and 2 in a
patient with homozygous mutant alleles (O20) further
supports our conclusion that the alleles G-G are linked to
the disease locus in this cohort, as previously established
for other Indian SCA1 families [13].
Discussion
In this study, we identify both pre-symptomatic and symp-
tomatic SCA1 individuals in Adukkamparai using a non-
invasive screening strategy. Our study shows important
phenotype-genotype correlations in a population prac-
ticing consanguineous marriage for generations. The
range of expanded alleles (40–51) in patients from this
village was comparable to those that have already been
reported in the Indian population [14,16-18]. As com-
pared with other studies, where 66% of the variation in
age of onset is accounted by CAG repeat size (26), our
Figure 4 Genotyping of SCA1. (a) Schematic diagram showing the
position of the two SNPs within the ATXN1 gene. (b) Representative
allelic discrimination plots for the rs2075974 (SNP1) showing
homozygous for A in blue and homozygous for G in red and
heterozygous (AG) in green and negative control (NTC) in black for
the samples from the cohort. (c) Representative allelic discrimination
plots for the rs1476464 (SNP2) showing the allele calls for
homozygous for T in red and heterozygous (TG) in green, and the
negative controls in black for the samples from the cohort.
Table 2 Association of the SNPs between normal and





SNP1 AA 12/59 (0.20) 0/17 (0) 0/16 (0)
GG 12/59 (0.20) 11/17 (0.64) 8/16 (0.5)
AG 35/59 (0.59) 6/17 (0.35) 8/16 (0.5)
SNP2 GG 0/59 (0) 1/17 (0.05) 0/16 (0)
TT 59/59 (1) 0/17 (0) 0/16 (0)
TG 0/59 (0) 16/17 (0.94) 16/16 (1)
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patients is only accounted to 45% by the repeat size.
Moreover, the age of onset in individuals with paternally
inherited alleles is earlier than in individuals with maternally
inherited alleles and this appears to be independent of the
size of CAG repeats. No marked anticipation was observed.
The prevalence of SCA1 varies in different regions and
has been attributed to the presence of a higher frequency
of large normal alleles (>30 repeats) and due to single
interruptions in normal alleles within the population
[12,13,22,27]. Trinucleotide disorders are known to harbor
alleles of large size in the normal range (large normal
alleles) that are unstable and therefore prone to expansions
into the disease range. Thus a higher frequency of large
normal alleles in a population is an indirect measure of the
prevalence of the disease [27-29]. In our study we did not
observe a high frequency of large normal alleles (0.21) as
compared to the frequency of small normal alleles (0.78).
African [6] and Siberian Sakha [7] cohorts having a high
prevalence of SCA1 have also reported a low frequency of
large normal alleles. The Siberian Sakha population, how-
ever had a higher proportion of individuals with single
CAT interruptions within the normal alleles [12]. It is
hypothesized that loss of CAT interruptions predisposes a
stable allele to further expansions [22]. We therefore
assume that the high prevalence of SCA1 we observe at
Adukkamparai could be contributed by expansions of non-
affected alleles carrying single CAT interruptions, which
were lost over time.
When the chromosomal background of the expanded
ATXN1 was tested for SNPs known to be associated with
CAG expansions, the results correlated with those from
previous studies carried out in SCA1 patients from
Southern and Northern India [13]. An association of the
genotypes G and G at loci (rs1476464 and rs2075974)
was found in these patients. These G-G alleles can thus
provide additional markers for the diagnosis of SCA1.
This is the first study highlighting this association of two
SNP’s (G-G) within an ethnic community in Tamil Nadu.
Therefore, although prevalence of SCA1 in southern
India seems to be more, there does not seem to be a
different founder from North India.
Very recent implementation of personalized gene silencing
by SNP-directed approaches is being considered as a poten-
tial therapeutic strategy in Huntington’s disease, another
triplet repeat disorder [30]. SNP-directed gene silencing
approaches are likely to be tried in future in the context of
personalized medicine. By identifying SNPs associated with
SCA1 in the cohort this study paves the way for selective
silencing of disease alleles using SNP-targeted approaches in
the future.
The existence of four individuals in the cohort who are
asymptomatic and beyond the threshold age of onset could
be attributed to differences in environmental conditions.
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of life style and dietary habits of both symptomatic and
asymptomatic individuals within a small geographic region.
Three asymptomatic individuals are females who share
similar lifestyles (house-wives) and occupation (farming)
with symptomatic females from the cohort. The male
asymptomatic individual (age 50 years) is a farmer and an
occasional contract laborer, and shares his lifestyle and oc-
cupation with a symptomatic male. The absence of smok-
ing and alcohol usage among all the pre-symptomatics
might suggest an apparent “protective” life style. However,
the numbers are currently too few for a statistical compari-
son between the two groups. Rather, these asymptomatic
individuals suggest the presence of genetic modifiers such
as SNPs and epigenetic changes for the pathogenesis of
SCA1 and in manifestation of symptoms. Previous studies
in other populations have reported similar presymptomatic
individuals beyond the age of onset and have suggested in-
complete penetrance of the mutation as the cause [7].Conclusions
Genome wide linkage scans [31,32], exome sequencing
[33] and targeted gene sequencing [34] by Next Gener-
ation Sequencing could be employed for identifying
the genetic modifiers proposed from the findings of
this study and previous studies. Further molecular and
genetic studies in individuals from the Adukkamparai
cohort and the other cohorts with greater numbers of pre-
symptomatic individuals carried out over time will aid in
providing a mechanistic perspective and natural history of
disease progression. These studies would eventually help in
determining and targeting therapeutic interventions based
on various stages of the disease.
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